Episode 15: The Latest Developments in the SMA Treatment Landscape
"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Richard Finkel, MD.
Richard Finkel, MD
Episode 15 of the NeurologyLive
The Mind Moments podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis, Parkinson disease, dementia, sleep disorders, and more.
Episode 15, "A New Approval: The SMA Treatment Landscape," features an interview with Richard Finkel, MD, pediatric neurologist, and head, Center for Experimental Neurotherapeutics, St. Jude Children’s Research Hospital. Finkel offered an in-depth look at how the recent FDA approval of oral risdiplam (Evrysdi; Roche) might impact the spinal muscular atrophy (SMA) therapeutic landscape.
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.